Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Change Healthcare Lawsuit Lawyers are reviewing Change Healthcare class action lawsuits for individuals who had their personal information stolen due to the data breach.
AngioDynamics Port Catheter Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Processed Food Lawsuit Lawsuits are being pursued against the food industry over their manufacturing and advertising of ultra-processed foods, which have caused a generation of children to face an increased risk of developing childhood diabetes and other chronic illnesses.
AFFF Lawsuit Exposure to firefighting foam chemicals may result in an increased risk of cancer for firefighters, military and airport personnel.
FDA Requires New Opioid Label Warnings Over Risks Of Suddenly Stopping Treatment April 10, 2019 Irvin Jackson Add Your Comments Federal regulators have called for new label warnings on opioid drugs about the risks of quitting the addictive pain killers suddenly or too quickly, which can lead to withdrawal, use of illicit drugs, and recurrence of severe pain and other complications. The FDA issued a drug safety communication on Monday, warning that it has received reports of serious harm occurring when patients who are physically dependent on opioid pain medications quit them too quickly. The agency is requiring changes to the prescribing information for any opioids intended for use in an outpatient setting, providing information about the sudden discontinuation risks for consumers, and a guide for doctors on how to safely decrease, and eventually discontinue, opioid treatment. Do You Know about… hair dye cancer lawsuits For Salon Professionals Hair dye lawsuits are being pursued for salon professionals who were routinely exposed to hair dye chemicals and diagnosed with bladder cancer or breast cancer. See if you qualify for a hair dye cancer lawsuit settlement. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Do You Know About… hair dye cancer lawsuits For Salon Professionals Hair dye lawsuits are being pursued for salon professionals who were routinely exposed to hair dye chemicals and diagnosed with bladder cancer or breast cancer. See if you qualify for a hair dye cancer lawsuit settlement. Learn More SEE IF YOU QUALIFY FOR COMPENSATION According to the agency, rapidly stopping opioid pain killers can lead to uncontrolled pain and withdrawal symptoms. This can cause patients to seek other opioids, including illegal drugs. The FDA notes that in these cases, patients attempting to alleviate pain using heroin and other substances are not necessarily addicted. “These may be signs of addiction (or opioid use disorder), but they may also be signs that a patient is physically dependent and has stopped opioid treatment too suddenly,” Dr. Douglas Throckmorton, deputy director of the FDA’s Center for Drug Evaluation and Research, said in a press statement on April 9. “There is an appropriate, evidence-based, safe way to taper opioids that can avoid severe side effects and minimize risks. Critically important, any taper must be tailored to the individual patient’s clinical and personal situation because of the many factors involved.” Throckmorton noted the FDA has received reports of serious harm, withdrawal symptoms, uncontrolled pain and suicide among patients who were physically dependent on opioids, but not considered addicted. The FDA is advising health care professionals not to abruptly discontinue opioids in patients who are physically dependent. Instead they should develop a patient-specific plan to taper the dose based on their current dosage, the duration of treatment, the type of pain being treated and other factors. The agency notes there is no standard opioid tapering schedule suitable for all patients, so individual plans will be needed which should seek to avoid serious withdrawal symptoms, worsening the patient’s pain, and which should seek to avoid psychological distress. Patients are advised not to suddenly stop taking opioids without first consulting with their health care professional for a plan on slowly decreasing use while continuing to manage pain. The FDA notes that even when the discontinuation is managed, patients may still experience withdrawal symptoms, and they should contact their health care professional if they experience increased pain, changes in mood or thoughts of suicide. Throckmorton said that the FDA plans to soon put forward new policies to address the ongoing opioid crisis, including evidence-based prescribing guidelines and fixed-quantity packaging for immediate-release formulations. The opioid crisis claims more and more lives each year, due to accidental and intentional overdoses associated with the powerful and addictive pain medications. In fact, Americans are now more likely to die from an opioid overdose than from a car crash. A report by the U.S. Centers for Disease Control and Prevention published late last year indicated opioids accounted for nearly 70% of all drug overdose deaths. Tags: Drug Abuse, Drug Addiction, Drug Side Effects, Opioids More Lawsuit Stories More Than 12,000 Hair Relaxer Cancer Lawsuits Filed Against L’Oreal, Other Cosmetics Companies April 17, 2025 AngioDynamics SmartPort Infection Resulted in Removal of Failed Port Catheter: Lawsuit April 17, 2025 Allstate Driving Data Collection Lawsuits Consolidated in Northern District of Illinois April 17, 2025 1 Comments DL April 10, 2019 This is ridiculous. The whole opioid problem was doctors giving patients pills like they were candy. Now you can’t even get them. I have severe chronic pain and sometimes need to take something stronger than the meds I am currently taking and it takes an act of Congress to get anything to help. I am not addicted to anything and need the pain relief, but can’t get anything. Went from giving it out to cutting it out and that is not right. As a 100% Disabled Veteran, I can’t get it any opioids from anyone, especially the VA. This is ridiculous and they need to have normal guidelines about giving opioids instead of the give them out and not give them out policy that has been put in place. Why don’t we just let the stupid people die off from overdoses and give those that need them what they need for pain relief. Not being cruel, just practical. I have had 28 years of chronic sciatic nerve pain and I can’t even get an aspirin from a doctor no matter where I go. Why? This is a problem, yes, but the people abusing them should be jailed or let them just thin out the abusers by their illegal and inappropriate use. Not rocket surgery… Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermNameThis field is for validation purposes and should be left unchanged. Δ MORE TOP STORIES More Than 12,000 Hair Relaxer Cancer Lawsuits Filed Against L’Oreal, Other Cosmetics Companies (Posted: yesterday) Nearly a dozen different cosmetics companies face more than 12,000 hair relaxer lawsuits, involving claims that chemical straighteners caused women to develop uterine cancer, endometrial cancer, ovarian cancer and other injuries. MORE ABOUT: HAIR RELAXER LAWSUITUterine and Endometrial Cancer Caused by Hair Relaxer Products: Lawsuit (03/25/2025)Schedule for Hair Relaxer Lawsuit Bellwether Trials Outlined by MDL Judge (03/13/2025)Synthetic Braiding Hair Contains Cancer-Causing Chemicals: Consumer Reports (03/05/2025) Paraquat Settlement Reached for Parkinson’s Disease Lawsuits Filed in MDL (Posted: 2 days ago) Lawyers involved in Paraquat Parkinson’s disease lawsuits pending in the federal court system indicate that they have reached an agreement to settle many of the claims. MORE ABOUT: PARAQUAT PARKINSON’S DISEASE LAWSUITSAppeals Court Urged To Reinstate Paraquat Lawsuits Previously Set for Bellwether Trials (02/14/2025)Paraquat Lawsuits Over Parkinson’s Disease Risk Set for Trial in October 2025, April 2026 (01/29/2025)Farmers Exposed to Certain Pesticides Face an Increased Risk of Rheumatoid Arthritis (12/11/2024) Status of Suboxone Tooth Loss Lawsuits To Be Reviewed at MDL Conference (Posted: 2 days ago) A federal judge will meet with lawyers involved with Suboxone tooth loss lawsuits tomorrow, to review the status of pretrial proceedings in claims brought by individuals throughout the U.S. MORE ABOUT: SUBOXONE TOOTH DECAY LAWSUITPrenatal Opioid Exposure May Result in Smaller Brains Among Newborns: Study (04/14/2025)Suboxone Lawsuit Filing Deadline Nears for Many Tooth Decay Claims in 3-Year SOL States (04/07/2025)Up to 100 Suboxone Tooth Decay Claims Can Be Filed on Single Lawsuit in MDL: Judge (03/17/2025)
More Than 12,000 Hair Relaxer Cancer Lawsuits Filed Against L’Oreal, Other Cosmetics Companies April 17, 2025
AngioDynamics SmartPort Infection Resulted in Removal of Failed Port Catheter: Lawsuit April 17, 2025
Allstate Driving Data Collection Lawsuits Consolidated in Northern District of Illinois April 17, 2025
More Than 12,000 Hair Relaxer Cancer Lawsuits Filed Against L’Oreal, Other Cosmetics Companies (Posted: yesterday) Nearly a dozen different cosmetics companies face more than 12,000 hair relaxer lawsuits, involving claims that chemical straighteners caused women to develop uterine cancer, endometrial cancer, ovarian cancer and other injuries. MORE ABOUT: HAIR RELAXER LAWSUITUterine and Endometrial Cancer Caused by Hair Relaxer Products: Lawsuit (03/25/2025)Schedule for Hair Relaxer Lawsuit Bellwether Trials Outlined by MDL Judge (03/13/2025)Synthetic Braiding Hair Contains Cancer-Causing Chemicals: Consumer Reports (03/05/2025)
Paraquat Settlement Reached for Parkinson’s Disease Lawsuits Filed in MDL (Posted: 2 days ago) Lawyers involved in Paraquat Parkinson’s disease lawsuits pending in the federal court system indicate that they have reached an agreement to settle many of the claims. MORE ABOUT: PARAQUAT PARKINSON’S DISEASE LAWSUITSAppeals Court Urged To Reinstate Paraquat Lawsuits Previously Set for Bellwether Trials (02/14/2025)Paraquat Lawsuits Over Parkinson’s Disease Risk Set for Trial in October 2025, April 2026 (01/29/2025)Farmers Exposed to Certain Pesticides Face an Increased Risk of Rheumatoid Arthritis (12/11/2024)
Status of Suboxone Tooth Loss Lawsuits To Be Reviewed at MDL Conference (Posted: 2 days ago) A federal judge will meet with lawyers involved with Suboxone tooth loss lawsuits tomorrow, to review the status of pretrial proceedings in claims brought by individuals throughout the U.S. MORE ABOUT: SUBOXONE TOOTH DECAY LAWSUITPrenatal Opioid Exposure May Result in Smaller Brains Among Newborns: Study (04/14/2025)Suboxone Lawsuit Filing Deadline Nears for Many Tooth Decay Claims in 3-Year SOL States (04/07/2025)Up to 100 Suboxone Tooth Decay Claims Can Be Filed on Single Lawsuit in MDL: Judge (03/17/2025)